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Abstract We characterized the neuronal two-domain (95kD-
K12.1) form of the K12.1 subunit of the voltage-gated calcium
channels using genetic and molecular analysis. The 95kD-K12.1
is absent in neuronal preparations from CACNA1A null mouse
demonstrating that K12.1 and 95kD-K12.1 arise from the same
gene. A recombinant two-domain form (K1AIII) of K12.1 asso-
ciates with the L subunit and is tra⁄cked to the plasma mem-
brane. Translocation of the K1AIII to the plasma membrane
requires association with the L subunit, since a mutation in
the K1AIII that inhibits L subunit association reduces membrane
tra⁄cking. Though the K1AIII protein does not conduct any
voltage-gated currents, we have previously shown that it gener-
ates a high density of non-linear charge movements [Ahern et
al., Proc. Natl. Acad. Sci. USA 98 (2001) 6935^6940]. In this
study, we demonstrate that co-expression of the K1AIII signi¢-
cantly reduces the current amplitude of K12.1/L1a/K2N channels,
via competition for the L subunit. Taken together, our results
demonstrate a dual functional role for the K1AIII protein, both
as a voltage sensor and modulator of P/Q-type currents in re-
combinant systems. These studies suggest an in vivo role for the
95kD-K12.1 in altering synaptic activity via protein^protein in-
teractions and/or regulation of P/Q-type currents.
9 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
High voltage-gated calcium channels play important roles
in intracellular and intercellular communication. The channels
allow Ca2þ in£ux into the cells in response to depolarization
and hence serve as transducers of electrical information into
cellular signals resulting in muscle contraction, hormone se-
cretion, neurotransmitter release and regulation of gene tran-
scription [2,3]. Di¡erent classes of high voltage-gated channels
(L, N, R and P/Q) have been de¢ned on the basis of their
biophysical characteristics and sensitivity to pharmacological
agents and serve specialized roles [3] in their tissue of expres-
sion. The P/Q- and the N-type channels predominantly func-
tion in neurotransmitter release at central synapses [4] and the
neuromuscular junction [5], while the L-type channels func-
tion in excitation^contraction coupling in the skeletal and
cardiac muscles [6,7].
At the molecular level, these channels are heteromultimers
of di¡erent subunits composed of at least the K1, K2N and L
subunits [8^10]. In addition, the skeletal muscle channel also
contains a Q1 subunit [11] and recently other Q subunits have
been identi¢ed [12^14]. The Q2 and Q3 subunits are associated
with the neuronal channels [15], suggesting that the four-sub-
unit complex is a common feature of the high voltage-gated
Ca2þ channel composition.
The K1 subunit, a large hydrophobic protein with 24 trans-
membrane regions distributed over four domains, forms the
voltage sensor and the pore of the channel to allow Ca2þ
in£ux into the cell in a voltage-dependent manner. The other
subunits are auxiliary and serve to modulate the tra⁄cking
and the biophysical properties of the channel [2]. Alternative
forms of each of the Ca2þ channel subunits arise by a variety
of mechanisms including splicing, editing and post-transla-
tional modi¢cations of the protein [16^18]. These variant
forms contribute to the diversity of biophysical properties
and functions for the channels.
Previous studies on puri¢ed channel preparations and syn-
aptic plasma membranes from rabbit brain have demonstrated
the existence of a 95 kDa two-domain form of the K12.1 sub-
unit [19]. This protein is predicted to be composed of the
amino terminus, the ¢rst two transmembrane domains and a
part of the II^III loop of the K12.1 subunit [19]. The 95kD-
K12.1 protein is enriched in synaptic membranes, is glycosy-
lated and binds to the L subunit. In addition to the rabbit
brain, this protein is expressed in the Sertoli cells of the testes
[20]. However, the role of the protein in vivo and the nature
of its origin remain unknown.
In this study, we demonstrate that the 95kD-K12.1 is en-
riched in the rabbit cerebellum. Further, using a mouse that is
genetically targeted to ablate the CACNA1A gene, we show
that both the full-length K12.1 and the truncated 95kD-K12.1
proteins arise from the same gene. Moreover, we demonstrate
the ability of a similar recombinant protein (K1AIII) to form a
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complex with the L subunit and tra⁄c to the plasma mem-
brane. We have previously shown that the K1AIII protein can
generate gating currents [1]. In this study, we demonstrate
that, in addition to the ability to generate charge movements,
the protein inhibits P/Q-type currents in vitro. The mechanism
of inhibition of P/Q-type currents is by competition for the L
subunit, as indicated by the lack of e¡ect of the K1AIIIY392S
protein on the current amplitude. Taken together, these data
support a role for the 95kD-K12.1 protein in modulating or
¢ne-tuning neuronal responses, both by protein^protein inter-
actions and/or modulation of P/Q-type currents.
2. Materials and methods
2.1. Antibodies
The antibodies used in this study have been previously described ^
Sheep 37 against the K12.1/2.2 subunit [19], Sheep 49 against the L3
subunit [10] and VD21, a monoclonal antibody, against the L subunit
[8].
2.2. Enrichment of the voltage-gated calcium channels
Isolated brain regions from the rabbit brain were solubilized twice
in a bu¡er containing 50 mM Tris, pH 7.4, 1% digitonin, 0.5 M NaCl
and protease inhibitors. Equal amounts of protein were then used to
enrich for the 95kD-K12.1 using a combination of heparin enrichment
and an antibody column to the L subunit. The extracted material was
immunoblotted for the 95kD-K12.1 using the Sheep 37 antibody. Ali-
quots of the solubilized material (100 Wg of protein) were immuno-
blotted to examine the expression of the L3 and L4 subunits.
The K12.1 null mice (CACNA1A3/3) have been previously de-
scribed [21]. Brains were collected from 2 week old CACNA1A null
and control wild-type mice. Brain microsomes were solubilized in a
bu¡er containing 50 mM Tris, pH 7.4, 1% digitonin, 0.5 M NaCl and
seven protease inhibitors and the calcium channels enriched as de-
scribed above. The enriched material was immunoblotted with anti-
bodies to the K1 subunit (Sheep 37). The blots were then reprobed
with an antibody to the L3 subunit (Sheep 49).
2.3. Cell culture
tsA201 [22] and mdg (muscular dysgenic) cells [1] and baby hamster
kidney (BHK) cells stably expressing the K12.1=L1a/K2N subunits [12]
were grown and maintained in culture as described previously.
2.4. cDNA constructs
EGFPK12.1: This construct was generated by introducing an EGFP
fusion protein in frame at the amino terminus of the rabbit K12.1
(GenBank: X57477).
K1AIII : This construct has been previously described in [1]. The
¢nal construct contains the coding region of the K12.1 up to nt 3948.
K1AIIIY392S : An K1AIII construct with a single mutation at amino
acid 392 (Y392S) was engineered from the rabbit full-length
K12.1Y392S. The resulting construct was similar to the K1AIII con-
struct, except for the single amino acid change (Y to S) at position
392.
EGFPK1AIII : The EGFPK1AIII construct was generated using
standard techniques. The resulting construct would encode an
EGFP fusion protein of the K1AIII with the EGFP at the amino
terminus of the K1AIII.
EFGPK1AIIIY392S : This construct was derived by replacing a frag-
ment of the EGFPK1AIII with one from the K1AIIIY392S. The result-
ing construct encodes a protein similar to the EGFPK1AIII, except for
a single amino acid change (Y to S) at position 392.
L subunits: The rat L3 and L4 subunits in the expression vector
pCDNA3 and the L1b and L2a subunits in the pSG5 expression vector
were used in this study.
2.5. Transient transfection
All transfections for expression, co-immunoprecipitation and mi-
croscopy were carried out using the Ca2þ-phosphate technique that
has been previously described [22]. Transfection in mdg myotubes was
performed with the polyamine LT-1 (Panvera, Madison, WI, USA) by
mixing the cDNA of interest with CD8 cDNA encoding vector.
Transfected cells were identi¢ed by expression of the CD8 antigen
veri¢ed through binding to anti-CD8 beads. In case of the stable
BHK cell line expressing the K12.1=L1a/K2N subunits, transient trans-
fections were performed using the Ca2þ-phosphate method or the
Lipofectamine Plus Reagent (Gibco BRL, Grand Island, NY,
USA). In order to select positively transfected cells for electrophysio-
logical recording, a plasmid cDNA encoding the green £uorescent
protein (GFP; pGreen Lantern-1, Gibco BRL) was also added to
the DNA transfection mixture (molar ratio 1:1). Additionally, cells
were transfected with GFP only as a control for non-speci¢c e¡ects of
overexpression.
2.6. Cell lysate preparation
TsA201 cells were transiently transfected as described above. Cells
were washed in phosphate-bu¡ered saline (PBS) and then lysed in 1 ml
of bu¡er containing 50 mM HEPES, pH 7.4, 0.4 M NaCl, 1% Triton
X and 1 mM EDTA and protease inhibitors. The solubilized material
was isolated by centrifugation at 15 000 rpm for 15 min at 4‡C.
2.7. Co-immunoprecipitation
Cell lysates from transiently transfected cells were used for immu-
noprecipitation using an antibody to the L subunit. The immunopre-
cipitated material was separated on a gel and immunoblotted with
a⁄nity-puri¢ed antibodies (Sheep 37). Aliquots of the cell lysate
were also immunoblotted.
2.8. Confocal microscopy
TsA201 cells were transfected as described above with the cDNA
constructs encoding the EGFPK1AIII or the EGFPK1AIIIY392S with
or without the L subunit. Approximately 48 h after transfection, the
cells were washed and replated on coverslips. They were further incu-
bated for approximately 24 h. The cells were washed in PBS and ¢xed
in 4% paraformaldehyde. After extensive washing, the coverslips were
mounted in Perma£uor (Shandon, PA, USA). In some cases, the cells
were permeabilized and treated with propidium iodide to visualize the
cell nuclei. All images were obtained on a confocal microscope (Bio-
Rad, CA, USA) with a magni¢cation of 200U. More than 200 cells
from independent transfections were counted for each set. Student’s
t-test was used for data analysis and P6 0.05 was used as signi¢cant.
The data were plotted using Sigma Plot and results are presented as
meanUS.E.
2.9. Electrophysiology
Ba2þ currents through Ca2þ channels were recorded from BHK
cells according to the whole-cell patch-clamp technique. All recordings
were performed at room temperature using an Axopatch 200A patch-
clamp ampli¢er (Axon Instruments, Foster City, CA, USA) and 2^4
M6 micropipettes manufactured from borosilicate glass capillary
tubes. To avoid problems with spatial control of currents, only indi-
vidual cells were selected for recording. Unless stated, cells were
clamped at a holding potential of 390 mV and capacity transients
were electronically compensated. Currents were evoked by 40-ms de-
polarizing voltage steps (0.05 Hz) to test potentials ranging from 340
to +70 mV. Linear leak and residual capacity currents were subtracted
on-line using a P/4 standard protocol. Current records were captured
on-line and digitized at a sampling rate of 20 kHz following ¢ltering
of the current record (5 kHz; four-pole Bessel ¢lter) using a personal
computer attached to a TL-1 interface (Axon). Pulse protocols, data
capture and analysis of recordings were performed using pCLAMP
software (Axon). Cells were bathed in a solution containing (in mM):
BaCl2 10; tetraethylammonium chloride (TEA-Cl) 125; HEPES 10;
glucose 5. Bath solution was adjusted to pH 7.3 with TEA-OH and
300 mosml l31 with sucrose. The internal (patch pipette) solution
consisted of (mM): CsCl 135; MgCl2 5; EGTA 10; HEPES 10;
ATP (magnesium salt) 4; GTP 0.1 (pH 7.3/CsOH, 286 mosml l31).
3. Results
3.1. The 95kD-K12.1 protein of the voltage-gated P/Q-type
calcium channel is enriched in the cerebellum
We have previously described the existence of the two-do-
main 95kD-K12.1 in the rabbit brain [19]. To determine the
distribution of the protein in di¡erent regions of the brain,
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which would be related to its functional roles, we decided to
examine the expression of the 95kD-K12.1 in the cerebellum,
cerebral cortex, hippocampus and thalamus from the rabbit
brain. The 95kD-K12.1 was enriched using a technique similar
to the one that has been previously described [19]. The en-
riched material was immunoblotted to examine the presence
of the 95kD-K12.1 protein. Aliquots of the solubilized materi-
al were also immunoblotted with di¡erent antibodies to exam-
ine the expression of the other subunits of the voltage-gated
calcium channels (Fig. 1). Our results clearly demonstrate that
the 95kD-K12.1 protein is enriched in the cerebellum and, to a
lower extent, in the cerebral cortex. Expression is also ob-
served in the hippocampus and the thalamus. The expression
levels of the L4 subunit in the cerebellum and cortex closely
appear to follow that of the 95kD-K12.1. On the other hand,
the L3 subunit is enriched in the cerebral cortex and thalamus
and is expressed at a lower level in the hippocampus. The L3 is
also expressed in the cerebellum, but to a much lower extent.
3.2. The 95kD-K12.1 protein of the voltage-gated P/Q-type
calcium channel is a product of the CACNA1A gene
To determine whether the 95kD-K12.1 protein of the vol-
tage-gated P/Q-type Ca2þ channels is a product of the CAC-
NA1A gene, we examined the presence of the protein in a
mouse with a targeted deletion of the CACNA1A gene that
completely eliminates both the transcript and the K12.1 pro-
tein [21]. We enriched the channels from the brains of the
CACNA1A null mice and age-matched wild-type control
mice using a heparin column followed by immunoa⁄nity
chromatography. The enriched material was then immuno-
blotted with an antibody that recognizes the 95kD-K12.1
(Fig. 2). The blots were then reprobed with an antibody to
the L subunit to demonstrate the enrichment of the L3 sub-
unit. Our data show that though the L3 subunit is enriched in
the preparations, the 95kD-K12.1 protein is absent in the
CACNA1A null mice, con¢rming that both the full-length
K12.1 and the two-domain 95kD-K12.1 are products of the
same gene. 3.3. Expression of recombinant two-domain constructs in
tsA201 cells
To assess the auxiliary subunit interactions and examine the
ability of the two-domain form of the K12.1 subunit to con-
duct voltage-gated calcium currents, we engineered a con-
struct that extends from the N terminal of the K12.1, through
the ¢rst two sets of transmembrane domains and part of the
II^III loop (Fig. 3A). From available data, this would be a
good approximation of the native protein [19]. A similar con-
struct with a mutation (Y392S) in the alpha interaction do-
main (AID) was also engineered (Fig. 3A) to study interaction
of the protein with the L subunit. The AID [23] is a high-
a⁄nity interaction site that mediates its interaction with a
corresponding region on the L subunit [24]. A single mutation
(Y392S) in this site has been previously shown to inhibit the
interaction of the K1 and the L subunits [23]. Similar two-
domain constructs with enhanced green £uorescent protein
(EGFP) fusion proteins at the N terminus (Fig. 3A) were
also generated to allow studies on the tra⁄cking of the
protein. Previous studies have shown that the presence of
an EGFP tag at the amino terminus of the K12.1 subunit
does not alter its electrophysiological properties [25] ; hence
we chose to insert the EGFP at the N terminus of the pro-
tein.
The expression of the constructs was examined by transient
Fig. 1. The 95kD-K12.1 protein is enriched in the cerebellum. The
cerebellum, cerebral cortex, hippocampus and thalamus from the
rabbit brain were homogenized and the voltage-gated calcium chan-
nels enriched using heparin chromatography and an antibody col-
umn to the L subunit. The presence of the 95kD-K12.1 was exam-
ined using an antibody to the K12.1/2.2 subunit (Sheep 37). The
95kD-K12.1 is enriched in the cerebellum and the cerebral cortex
with lower expression in the hippocampus and thalamus.
Fig. 2. The 95kD-K12.1 protein is a product of the CACNA1A
gene. Brain microsomes from wild-type (+/+) and CACNA1A null
(3/3) mice were homogenized and the voltage-gated Ca2þ channels
enriched using heparin a⁄nity chromatography and enrichment with
an antibody to the L subunit. The presence of the 95kD-K12.1 pro-
tein was examined in the immunoprecipitated material by immuno-
blotting with an antibody to the K12.1/2.2 subunit (Sheep 37). The
95kD-K12.1 protein is absent in the CACNA1A null mice. The blot
was then reprobed with an antibody to the L3 subunit to demon-
strate enrichment of the channels.
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Fig. 3. Schematic of constructs and expression in mammalian cells. A: Four di¡erent constructs were used in this study. The K1AIII contains
the portion of the rabbit K12.1 subunit from the N-terminal and the ¢rst two sets of transmembrane domains through a part of the II^III
loop. The K1AIIIY392S is similar to the K1AIII, except for a single point mutation, Y392S, in the AID region containing the high-a⁄nity bind-
ing site for the L subunit. The EGFPK1AIII and EGFPK1AIIIY392S constructs are similar to the K1AIII and K1AIIIY392S, respectively, except
that they encode an EGFP fusion at the N terminus of the protein. The schematic of the full-length K12.1/K1A with the four transmembrane
domains is shown for comparison. The antibody recognition epitope (Y) in the II^III loop is indicated. B: Heterologous expression of con-
structs in mammalian cells. tsA201 cells, transiently transfected with the constructs described above, were lysed and the expression of the pro-
teins was examined by immunoblotting with an antibody to the K1 subunit. All the constructs showed expression of the proteins.
Fig. 4. The K1AIII and the L3 subunits can form a complex. tsA201 cells were transiently transfected with either no DNA, K1AIII, K1AIII and
L3, L3 only or K1AIIIY392S and L3. The cells were lysed and immunoprecipitated with an antibody to the L subunit. The immunoprecipitated
material was immunoblotted to detect the presence of the K1AIII and the K1AIIIY392S. The cell lysates were also immunoblotted to examine the
expression of the indicated proteins. The antibodies used are indicated.
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transfection in tsA201 cells and immunoblot analysis (Fig.
3B). No endogenous protein was detected in the cells by the
antibody, consistent with the lack of endogenous channel ex-
pression. All the constructs directed robust expression of the
corresponding proteins in the transfected cells. Intriguingly,
the signal in the cells transfected with the EGFP-tagged con-
structs was observed as doublets. Although the identity of
such doublets is unknown, we speculate that these represent
proteolytic degradation during cell lysis.
3.4. The K1AIII forms a complex with the L subunit
Since the K1AIII protein contains the AID, we speculated
that it might form a complex with the L subunit. This inter-
action was examined in a cell culture system. To this end,
tsA201 cells were transiently transfected with di¡erent combi-
nations of recombinant subunits. Lysates from these cells were
then used to immunoprecipitate the L subunit and the proteins
that associate with it. The immunoprecipitates were examined
for the presence of the K1AIII and K1AIIIY392S proteins (Fig.
4). Aliquots of the cell lysate were also immunoblotted to
con¢rm expression of the transfected constructs. Consistent
with the lack of endogenous L subunits immunoprecipitated
by the antibody, the K1AIII does not immunoprecipitate in
the absence of transiently expressed L subunit. Conversely, in
the absence of transfected K1AIII, there is no endogenous
protein detected by the K1 antibody associated with the
L subunit. When both the K1AIII and the L3 are co-expressed,
they can be immunoprecipitated, con¢rming the ability of
the K1AIII protein to form a stable complex with the L3 sub-
unit. Further, a mutation in the high-a⁄nity AID motif
(K1AIIIY392S) severely inhibits the interaction, con¢rming
that the AID is indeed the predominant site of the interaction
between the K1 and the L subunits.
3.5. EGFPK1AIII is tra⁄cked to the plasma membrane in the
presence of the L subunits
To examine the ability of the K1AIII to translocate to the
plasma membrane, we took advantage of the EGFP-tagged
constructs. tsA201 cells were transiently transfected with these
constructs in the presence or absence of the L subunits and the
localization of the EGFP-tagged proteins was examined using
confocal microscopy. For every set of transfections, trans-
Fig. 5. Tra⁄cking of the EGFPK1AIII to the plasma membrane in the presence of the L subunit. A: tsA201 cells were transiently transfected
with (a) EGFPK1AIII, (b) EGFPK1AIII and L3, (c) EGFPK1AIIIY392S, (d) EGFPK1AIIIY392S and L3, (e) EGFPK12.1 and L3. The cells were
¢xed and the localization of the EGFP-tagged proteins was examined by confocal microscopy. Shown are transmission images, the nucleus as
visualized by propidium iodide staining and £uorescence images from the EGFP-tagged constructs. B: Cells from independent transfections of
the EGFPK1AIII, EGFPK1AIIIY392S and EGFPK12.1 in the presence or absence of the L subunits were counted to estimate the number of cells
that demonstrated plasma membrane or internal membrane staining. The plot shows the percentage of cells for each set of transfections that
exhibited membrane staining (*P6 0.05). Bars represent standard errors.
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fected cells were randomly counted and the numbers of cells
demonstrating plasma membrane or internal staining were
estimated. Statistical analysis was carried out on the numbers
obtained from di¡erent transfections. The EGFPK1AIII and
the EGFPK1AIIIY392S proteins were predominantly localized
in internal membranes (Fig. 5A). Co-expression of the L3 sub-
unit allowed a signi¢cant (Fig. 5A,B) increase in the plasma
membrane localization of the EGFPK1AIII protein (Fig. 5A).
A similar e¡ect was observed upon co-transfection with any of
the other L subunits, namely L1b, L2a and L4 (Fig. 5B). Con-
sistent with the severe disruption of the K1AIII/L3 interaction
by the presence of the AID mutation, the EGFPK1AIIIY392S
did not show this enhanced tra⁄cking in the presence of the
L3 subunit (Fig. 5A,B). We have previously demonstrated that
the two-domain K1AIII protein, in association with the L sub-
unit, can generate gating currents [1]. This is consistent with
the ability of the K1AIII protein to tra⁄c to the plasma mem-
brane in association with the L subunit. To compare these
results with those for the full-length K12.1 subunit, we exam-
ined the membrane localization of an EGFP tagged K12.1
subunit, co-expressed with the L3 subunit. The K11.1 protein
was localized to the membrane (Fig. 5A) to a similar extent as
the K1AIII protein (Fig. 5B). These results con¢rm both the
ability of the EGFPK1AIII to be localized at the plasma mem-
brane and the importance of the association with the L sub-
unit for the localization, similar to that observed with the
K12.1.
3.6. The K1AIII protein reduces the current amplitude of
K12.1/L1a/K2N-1 channels
To examine the e¡ect of the two-domain K1AIII protein on
currents generated by the full-length K12.1 subunit, the K1AIII
protein was transfected in a cell line (BHK) stably expressing
the K12.1/L1a/K2N-1 subunits [12]. To allow identi¢cation for
electrophysiological recording, cells were also co-transfected
with a cDNA encoding the GFP. In addition, as a control
for non-speci¢c e¡ects of overexpression of recombinant pro-
teins, cells were transfected with the GFP construct alone.
Voltage-gated Ca2þ currents were then recorded using the
whole-cell patch-clamp technique. Co-expression of the
K1AIII protein signi¢cantly reduced the current amplitude
generated by the K12.1/L1a/K2N-1 channels (Fig. 6A). Hence,
total whole-cell current amplitudes at maximally activating
voltages decreased about 30%, from a control value of
31794U 124 pA (n=9) in untransfected BHK cells to
31263U 232 pA (n=10) in the K1AIII-expressing cells
(P6 0.05). However, the kinetic properties of the currents,
including voltage dependence, activation and inactivation, re-
mained unaltered (data not shown). Consistent with the spec-
i¢city of this e¡ect, peak current density in BHK cells trans-
fected with GFP alone (31776U 278 pA, n=10) was virtually
the same as in the control cells. These data show that the
K1AIII protein signi¢cantly reduces the current amplitude of
the K12.1/L1a/K2N-1 channels. One possible explanation for the
inhibition of K12.1 currents is that K1AIII could act to seques-
ter free L subunits, and therefore limit the amount of K12.1
tra⁄cked to the plasma membrane. To test this, BHK cells
were transfected with the K1AIII construct with a point mu-
tation (Y392S). As shown in Fig. 6A,B no inhibitory e¡ect
was observed after transfection of K1AIIIY392S in cells express-
ing the full-length K12.1 subunit. IBa current amplitude at +20
mV in cells expressing K12.1 together with the K1AIIIY392S
construct was 3641U 117 pA (n=13), a non-signi¢cant
change compared with 3578U62 pA (n=10) for K12.1 in
the absence of K1AIIIY392S recorded in parallel from the
same transfections (Ps 0.05). The di¡erences in basal current
amplitudes in the cells used as controls for the K1AIII and the
K1AIIIY392S are presumably due to the di¡erent passage num-
bers of the cell lines used for these recordings. Taken together,
the results of the electrophysiological experiments suggest that
L subunit scavenging is a likely mechanism underlying the
inhibitory e¡ect of K1AIII.
Fig. 6. Current-amplitude reduction of the K12.1/L1a/K2N-1 channels with the K1AIII protein. A: Representative traces of Ba2þ currents induced
by activating pulses in BHK cells stably expressing K12.1/L1a/K2N-1 channels and transiently transfected with two K1AIII cDNA constructs in
the presence of GFP. Upper traces correspond to the currents recorded in control GFP only transfected cells and in BHK cells transfected
with the K1AIII. Lower current records were obtained in cells expressing GFP alone or GFP plus K1AIIIY392S. B: Comparison of peak Ba2þ
current amplitude in response to an activating pulse to +20 mV from a holding potential of 390 mV. Data are given as meanUS.E., and the
number of recorded cells is indicated in parentheses. Statistical signi¢cance of the di¡erence between K1AIII-transfected and control cells was
determined by Student’s t-test (*P6 0.05).
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4. Discussion
The 95kD-K12.1 protein [19] is a two-domain form of the
four-domain K12.1 Ca2þ channel subunit, extending from the
amino terminal of the full-length protein through a part of the
II^III loop. In the present study we show that: (i) the 95kD-
K12.1 protein is enriched in the cerebellum; (ii) the 95kD-
K12.1 protein is a product of the CACNA1A gene; and (iii)
a similar recombinant protein can form a complex with the
L subunit, translocate to the plasma membrane and function
both as a voltage sensor [1] and an inhibitor of P/Q-type Ca2þ
currents.
Our data clearly demonstrate that the 95kD-K12.1 is en-
riched in the cerebellum and is expressed in the cerebral cor-
tex, hippocampus and thalamus. Interestingly, the K12.1 is
also expressed in these regions [21,26]. It would be interesting
to assess if the generation of the 95kD-K12.1 and K12.1 pro-
teins is regulated in parallel. The L4 subunit is also robustly
expressed in the cerebellum and the cortex. It has been pre-
viously shown that the L4 subunit is the predominant subunit
associated with the K12.1 subunit. It is tempting to speculate
that the L4 subunit might then also be the predominant sub-
unit associated with the 95kD-K12.1 in vivo. However, further
studies are required to assess this association.
It is established that the K1 subunits are capable of inter-
acting with any of the four known L subunits and that the
AID is the predominant mediator of this interaction. This can
give rise to heterogeneity in the composition of the channel
complexes [10,27], hence contributing to the diversity of the
channels in terms of biophysical characteristics and function.
We demonstrate that the K1AIII interacts with the L3 subunit,
predominantly via the AID. This implies that all the L sub-
units interact with the 95kD-K12.1 protein, thus resulting in
heterogeneous complexes and functional diversity.
The four-transmembrane domain structure is common to
the pore-forming subunit of the voltage-gated channel super-
family. Alternatively spliced transcripts that encode truncated
forms of these subunits have been reported for a number of
channels [28^31]. Most of these have been considered as evo-
lutionary precursors of the ion-conducting subunits of the
voltage-gated channel superfamily with no known function.
It is interesting that the K1AIII does not conduct voltage-
gated currents, similar to what has been observed for other
two-domain proteins. Our results suggest the two-domain
form of the 95kD-K12.1 subunit may have specialized physio-
logical roles, raising the possibility that the other truncated
channel proteins may represent evolutionary precursors with
signi¢cant physiological function.
The exact nature of physiological origin of the 95kD-K12.1
protein is unclear. The mechanism of generation of the other
two-domain proteins suggests that an alternative transcript
generates the 95kD-K12.1 protein. We have previously dem-
onstrated [19] that the 95kD-K12.1 protein is similar to the
K12.1 in terms of the amino terminal sequence, suggesting a
common transcriptional start site for both proteins. Interest-
ingly, a variant of the K12.2 arises from an alternative tran-
script in which the known exon^intron boundaries are not
retained [32]. The mechanism of generation of this transcript
is also unclear, suggesting that alternative transcript-generat-
ing mechanisms may exist.
Our data demonstrate that the EGFPK1AIII can localize to
the plasma membrane. As with the K12.1 subunit, this mem-
brane tra⁄cking is augmented by the co-expression of the
L subunit. The role of the L subunits in the membrane traf-
¢cking of the K1 subunits has been well documented. Recent
data suggest that this may be due to the ability of the L sub-
unit to circumvent the endoplasmic reticulum retention signal
in the K1 subunits [33]. Presumably, similar mechanisms oper-
ate in the tra⁄cking of the 95kD-K12.1 and the K1AIII to the
plasma membrane. Moreover, our data suggest an important
role for the ¢rst half of the K12.1 in the tra⁄cking of the
protein to the plasma membrane. The ability of the AID
mutation (Y392S) to restrict the membrane tra⁄cking of the
K1AIII protein is also consistent with previous studies that
demonstrate the importance of this site in the association of
the K1 and L subunits, and also the signi¢cance of this inter-
action for the ability of the L subunit to aid the tra⁄cking of
the protein to the membrane [34].
We have previously demonstrated that the truncated two-
domain K1AIII protein, in association with the L subunit, can
generate gating currents in dysgenic myotubes [1]. The ability
of the K1AIII to function as a voltage sensor, similar to that
observed with a two-domain form of the K11.1 [1], indicates
that the protein can undergo conformational changes in re-
sponse to membrane depolarization. The P/Q-type channels
are coupled to the exocytotic machinery and serve to link
the depolarization-dependent Ca2þ in£ux to neurotransmitter
release. The II^III loop of the K12.1 subunit serves as a bind-
ing site for a number of proteins associated with the exocy-
totic machinery including syntaxin, SNAP-25 [35], synapto-
tagmin [36] and cysteine string proteins [37]. Since the
95kD-K12.1 protein may possess at least some of the sites
required for interaction with these proteins, we anticipate
that it may interact with the synaptic vesicle proteins and
couple depolarization to Ca2þ-insensitive neurotransmitter re-
lease [38,39] by conformational changes associated with the
movement of gating charges.
Alternatively, the 95kD-K12.1 protein may couple to the
ryanodine receptor in the brain and be involved in intracellu-
lar Ca2þ release, via conformational coupling, similar to that
observed with Ca2þ-independent excitation^contraction cou-
pling in the skeletal muscle. The association of the neuronal
voltage-gated calcium channels with the ryanodine receptor is
only beginning to be revealed [40] and there is currently no
evidence to indicate that the non-L-type voltage-gated chan-
nels couple to the ryanodine receptor in the brain. However,
given the similarity between the di¡erent K1 subunits and the
wide expression of the ryanodine receptor in the brain, this
interaction may be possible in vivo. We propose that the
95kD-K12.1 protein may be involved in coupling to either of
the ryanodine receptor isoforms in the brain to mediate acti-
vation of the receptor, and hence calcium release and intra-
cellular calcium signaling, by mechanical coupling in response
to membrane depolarization.
In neurons, the inhibitory function of the 95kD-K12.1 pro-
tein might serve as a mechanism for regulation of current
amplitude of the P/Q-type channels and hence neurotransmit-
ter release and synaptic activity. As a precedent for this kind
of regulatory role in voltage-gated channels, it has been dem-
onstrated that truncated forms of the potassium channel
KvLQT1 [41] and truncated forms of the ascidian L-type
Ca2þ channel K1 subunit [42] can e¡ectively reduce the current
amplitude of the full-length subunits. The K1AIII protein re-
duces the current amplitude of the K12.1 subunit by direct
FEBS 26799 5-12-02 Cyaan Magenta Geel Zwart
J. Arikkath et al./FEBS Letters 532 (2002) 300^308306
competition for the L subunit. Interestingly, it has been dem-
onstrated that a truncated form of the K12.2 protein, similar
in structure to the 95kD-K12.1 protein, inhibits the currents
generated by the full-length K12.2 protein [43]. The mecha-
nism for this inhibition appears to be a direct e¡ect of the
truncated protein on the full-length protein and not via com-
petition for the L subunit. It is not clear why the mechanisms
of inhibition of the truncated K12.1 and K12.2 proteins di¡er,
though it is possible that this is related to the intrinsic nature
of the two pore-forming subunits.
Finally, genetic mutations in the CACNA1A gene have
been associated with episodic ataxia type 2, which is a rare
autosomal dominant disorder. Most of the known mutations
are predicted to result in truncated proteins [44], which retain
only some of the transmembrane domains of the full-length
protein. The mechanisms by which these mutations cause dis-
ease are not well understood. This study presents evidence
that raises the possibility that the truncated proteins produced
in the pathological conditions may possess physiological func-
tion and result in the disease phenotype by a gain of function
or inappropriate dominant inhibition of the P/Q-type channel
activity in the nervous system.
In summary, our data support a physiological role for the
95kD-K12.1 protein, in association with the L subunit, as a
voltage sensor and in the regulation of P/Q-type Ca2þ cur-
rents. Further studies are necessary to delineate the cells and
systems in which these roles are important and to determine
whether the protein arises by alternate splicing, editing or
post-translational modi¢cation of the full-length K12.1 pro-
tein. It would also be interesting to examine if the full-length
and truncated forms of the protein are expressed in the same
or di¡erent cell types and whether they are di¡erentially regu-
lated by extracellular stimuli or during development. Such
studies might reveal important roles for the protein in critical
neuronal processes including synaptic transmission and plas-
ticity.
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